| 8(1) |
S1AB |
None Cited |
Assay |
NULL |
| 8(1) |
G4 |
None Cited |
Assay and Identification |
2%. |
| 13(6) |
G19 |
OV-225 |
Assay and Identification |
0.25-µm capillary column. |
| 17(3) |
G19 |
None Cited |
Concomitant components |
NULL |
| 8(1) |
G4 |
None Cited |
Free . . . . . . . . . . . |
Free steroids. |
| 13(6) |
G19 |
OV-225 |
Free . . . . . . . . . . . |
Free steroids. |
| 17(3) |
G19 |
None Cited |
Limit of . . . . . . . . . |
Limit of 17-beta-estradiol and delta-8,9-dehydroestrone. |
| 8(1) |
G4 |
None Cited |
Limit of . . . . . . . . . |
Limit of 17a-dihydroequilin. |
| 8(1) |
S1AB |
None Cited |
Limit of . . . . . . . . . |
Limit of 17a-dihydroequilin. |
| 17(3) |
G43 |
None Cited |
Organic volatile impurities |
See Method V  467 |
| 17(3) |
G19 |
None Cited |
Signal impurities |
NULL |